Literature DB >> 23583895

Antibody responses induced in mice immunized with recombinant adenovectors expressing chimeric proteins of various porcine pathogens.

Elodie Roques1, Aurélie Girard, Carl A Gagnon, Denis Archambault.   

Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV), Porcine Circovirus type 2 (PCV2) and Mycoplasma (M.) hyopneumoniae are swine pathogens of economic importance. Although vaccines are available for each pathogen, no commercial bivalent vaccines have been developed so far. In this study, recombinant adenovectors (AdVs) expressing proteins of each pathogen were developed and their immunogenicity tested in mice. The proteins of interest were the glycoprotein GP5 of PRRSV, the capsid (Cap) protein of PCV2b and the C-terminal portion of P97 (P97c) protein of M. hyopneumoniae that were used alone and/or in fusion which each other. Inoculation of mice with the AdVs resulted in antibody (Ab) responses specific to the immunogens. Unexpectedly, immunization with vaccines expressing P97c in fusion to either Cap or GP5 enhanced the Ab responses against Cap and GP5, suggesting an immunopotentiator effect for P97c.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23583895     DOI: 10.1016/j.vaccine.2013.03.068

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  7 in total

1.  The Cholera Toxin B Subunit (CTB) Fused to the Porcine Arterivirus Matrix M and GP5 Envelope Proteins Fails to Enhance the GP5-Specific Antibody Response in Pigs Immunized with Adenovectors.

Authors:  Elodie Roques; Martin Lessard; Denis Archambault
Journal:  Mol Biotechnol       Date:  2015-08       Impact factor: 2.695

Review 2.  Perspectives for improvement of Mycoplasma hyopneumoniae vaccines in pigs.

Authors:  Dominiek Maes; Filip Boyen; Bert Devriendt; Peter Kuhnert; Artur Summerfield; Freddy Haesebrouck
Journal:  Vet Res       Date:  2021-05-08       Impact factor: 3.683

3.  Pathogenicity & virulence of Mycoplasma hyopneumoniae.

Authors:  Fernanda M A Leal Zimmer; Jéssica Andrade Paes; Arnaldo Zaha; Henrique Bunselmeyer Ferreira
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

4.  Immunogenicity and Protective Potential of Mucosal Vaccine Formulations Based on Conserved Epitopes of Influenza A Viruses Fused to an Innovative Ring Nanoplatform in Mice and Chickens.

Authors:  Cynthia Calzas; Molida Mao; Mathilde Turpaud; Quentin Viboud; Joelle Mettier; Thomas Figueroa; Pierre Bessière; Antoine Mangin; Laura Sedano; Pierre-Louis Hervé; Romain Volmer; Mariette F Ducatez; Steve Bourgault; Denis Archambault; Ronan Le Goffic; Christophe Chevalier
Journal:  Front Immunol       Date:  2021-11-11       Impact factor: 7.561

5.  Virus-like particles of chimeric recombinant porcine circovirus type 2 as antigen vehicle carrying foreign epitopes.

Authors:  Huawei Zhang; Ping Qian; Lifeng Liu; Suhong Qian; Huanchun Chen; Xiangmin Li
Journal:  Viruses       Date:  2014-12-05       Impact factor: 5.048

6.  Induction of robust immunity response in mice by dual-expression-system-based recombinant baculovirus expressing the capsid protein of porcine circovirus type 2.

Authors:  Yu Ye; Xiaoliang Cheng; Jie Zhang; Tiezhu Tong; Wenyao Lin; Ming Liao; Huiying Fan
Journal:  Virol J       Date:  2013-10-28       Impact factor: 4.099

7.  Immune responses induced by a combined vaccination with a recombinant chimera of Mycoplasma hyopneumoniae antigens and capsid virus-like particles of porcine circovirus type 2.

Authors:  Yu Tao; Rui Yang; Jianhong Shu; Wenqian Zheng; Jian Chen; Yuehong Wu; Yulong He
Journal:  BMC Vet Res       Date:  2020-09-16       Impact factor: 2.741

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.